NCT07042295 2026-03-18
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
1 trialsLocally Recurrent Skin Squamous Cell Carcinoma × Magnetic Resonance Spectroscopy × 90 days × Clear all